Published in Am J Public Health on March 01, 1986
GRACE: public health recovery methods following an environmental disaster. Arch Environ Occup Health (2010) 0.98
Bronchial hyperreactivity. Am Rev Respir Dis (1980) 4.77
An outbreak of waterborne giardiasis associated with heavy water runoff due to warm weather and volcanic ashfall. Am J Public Health (1983) 2.16
Environmental mesothelioma in Turkey. Ann N Y Acad Sci (1979) 2.11
Mount st. Helens ash from the 18 may 1980 eruption: chemical, physical, mineralogical, and biological properties. Science (1980) 2.06
Mount st. Helens volcano: recent and future behavior. Science (1975) 1.89
The relationship between tuberculosis and silicosis. Am Rev Respir Dis (1978) 1.89
Comparative pathology of silicate pneumoconiosis. Am J Pathol (1979) 1.76
Research issues and directions in the epidemiology of health effects of disasters. Epidemiol Rev (1981) 1.72
Silicate pneumoconiosis of farm workers. Lab Invest (1979) 1.68
Malignant mesotheliomas in a small village in the Anatolian region of Turkey: an epidemiologic study. J Natl Cancer Inst (1979) 1.55
Health implications of the Mount St. Helen's eruption: epidemiological considerations. Ann Occup Hyg (1982) 1.24
Airways responsiveness in a population sample of adults and children. Am Rev Respir Dis (1984) 1.21
Is volcanic ash a pneumoconiosis risk? Nature (1981) 1.20
Endemic pleural disease associated with exposure to mixed fibrous dust in Turkey. Science (1982) 1.15
Fiber carcinogenesis: epidemiologic observations and the Stanton hypothesis. J Natl Cancer Inst (1981) 1.14
Pneumoconiosis in the nonindustrial population of Rajasthan. J Indian Med Assoc (1958) 1.08
A striking deposition of mineral particles in the lungs of a farmer: a case report. Am J Ind Med (1984) 1.06
Deaths during the May 18, 1980, eruption of Mount St. Helens. N Engl J Med (1981) 0.95
Predicting eruptions at mount st. Helens, june 1980 through december 1982. Science (1983) 0.93
Volcanic gases and health: Masaya Volcano, Nicaragua. Lancet (1982) 0.93
OBSERVATIONS ON AIR POLLUTION ASPECTS OF IRAZ'U VOLCANO, COSTA RICA. Public Health Rep (1964) 0.92
Pleural calcification in north-west Greece. Lancet (1981) 0.89
Are volcanoes hazardous to your health? What have we learned from Mount St Helens? West J Med (1982) 0.88
Pyroclastic flow injury. Mount St. Helens, May 18, 1980. Am J Surg (1982) 0.85
Volcanoes to Keep an Eye on: The western United States has scores of volcanoes likely to erupt in the future; some of them may be waking from long slumbers. Science (1983) 0.83
Silica and silicates in femoral lymph nodes of barefooted people in Ethiopia with special reference to elephantiasis of the lower legs. Trans R Soc Trop Med Hyg (1979) 0.83
Comparative in vitro cytotoxicity of volcanic ashes from Mount St. Helens, El Chichon, and Galunggung. J Toxicol Environ Health (1984) 0.82
Health hazards of volcanic eruptions. J R Coll Physicians Lond (1983) 0.82
On the carcinogenic polycyclic aromatic hydrocarbon benzo(a)pyrene in volcano exhausts. Cancer Lett (1976) 0.77
Health effects of Mount St. Helens volcanic dust. Lab Invest (1983) 0.77
Edemic nephropathy and cancer of the upper urinary tract urothelium in Yugoslavia. Isr J Med Sci (1972) 0.77
Mineral dust and pulmonary lesions: etiological link or epiphenomenon? Am J Ind Med (1984) 0.77
[Conimetric & granulometric determination in various stages of operation in the pumice-stone industry in Canneto-Lipari (Messina)]. Acta Med Leg Soc (Liege) (1959) 0.76
[Respiratory functions in the early stages of tuff pneumoconiosis]. Gig Tr Prof Zabol (1980) 0.76
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med (2001) 27.83
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA (1994) 10.46
The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med (1992) 8.53
Global burden of COPD: systematic review and meta-analysis. Eur Respir J (2006) 7.00
Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax (2003) 4.81
Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89
Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med (2000) 3.43
Prevalence and prognosis of electrocardiographic findings in middle-aged men. Br Heart J (1978) 3.28
Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest (1999) 3.28
Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest (2000) 3.12
Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J (2002) 3.06
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax (2005) 2.69
A dynamic population model of disease progression in COPD. Eur Respir J (2005) 2.59
Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J (2009) 2.52
Major chemical disasters. BMJ (1991) 2.39
Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med (1999) 2.36
Specialty differences in the management of asthma. A cross-sectional assessment of allergists' patients and generalists' patients in a large HMO. Arch Intern Med (1997) 2.28
Volcanic ash and respiratory symptoms in children on the island of Montserrat, British West Indies. Occup Environ Med (2003) 2.25
Gender differences in smoking cessation after 3 years in the Lung Health Study. Am J Public Health (1995) 2.16
A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med (1994) 2.11
Estimation of human dose of staphylococcal enterotoxin A from a large outbreak of staphylococcal food poisoning involving chocolate milk. Int J Food Microbiol (1988) 2.10
Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial. Ann Intern Med (2001) 2.06
Spirometry in the Lung Health Study. 1. Methods and quality control. Am Rev Respir Dis (1991) 1.99
Predicted values for closing volumes using a modified single breath nitrogen test. Am Rev Respir Dis (1973) 1.89
Present and future costs of COPD in Iceland and Norway: results from the BOLD study. Eur Respir J (2009) 1.89
Absence of relationship between tuberculin reactivity and atopy in BCG vaccinated young adults. Thorax (2000) 1.88
Chronic Obstructive Pulmonary Disease Early Intervention Trial (Lung Health Study). Baseline characteristics of randomized participants. Chest (1993) 1.85
Letter: Angiosarcoma of the liver as the certified cause of death 1963-73. Lancet (1975) 1.84
Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity? Am Rev Respir Dis (1993) 1.82
Laboratory animal allergy in a pharmaceutical company. Br J Ind Med (1988) 1.73
Replacement therapy for hereditary alpha1-antitrypsin deficiency. A program for long-term administration. Chest (1994) 1.71
Preventing deaths from asthma. N Engl J Med (1994) 1.70
Can a normal peak expiratory flow exclude severe chronic obstructive pulmonary disease? Int J Tuberc Lung Dis (2009) 1.60
Mount St Helens eruptions, May 18 to June 12, 1980. An overview of the acute health impact. JAMA (1981) 1.59
The laryngeal mask airway: a comparison between two insertion techniques. Anesth Analg (1997) 1.56
Quantitative analysis of the alveolar plateau in the diagnosis of early airway obstruction. Am Rev Respir Dis (1973) 1.56
Restricted spirometry in the Burden of Lung Disease Study. Int J Tuberc Lung Dis (2012) 1.55
Characteristics of patients with asthma within a large HMO: a comparison by age and gender. Am J Respir Crit Care Med (1998) 1.53
Angiosarcoma of the liver: annual occurrence and aetiology in Great Britain. Br J Ind Med (1980) 1.52
Relative impact of smoking and reduced pulmonary function on peptic ulcer risk. A prospective study of Japanese men in Hawaii. Gastroenterology (1989) 1.52
Monitoring recruitment effectiveness and cost in a clinical trial. Control Clin Trials (1993) 1.49
Letter: Angiosarcoma of the liver in P.V.C. fabricators. Lancet (1976) 1.44
Associations of smoking with hospital-based care and quality of life in patients with obstructive airway disease. Chest (1999) 1.42
COPD exacerbations: the importance of a standard definition. Respir Med (2004) 1.42
Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med (1994) 1.42
Recruiting hard-to-reach subjects: is it worth the effort? Control Clin Trials (1994) 1.41
Effects of smoking and smoking cessation on longitudinal decline in pulmonary function. Am J Respir Crit Care Med (1995) 1.40
20-year trends in the prevalence of asthma and chronic airflow obstruction in an HMO. Am J Respir Crit Care Med (1998) 1.40
Lead hazard in British stained glass workers. Br Med J (Clin Res Ed) (1985) 1.38
Caesarean section delivery and the risk of allergic disorders in childhood. Clin Exp Allergy (2005) 1.36
Mount St. Helens eruptions: the acute respiratory effects of volcanic ash in a North American community. Arch Environ Health (1983) 1.34
A comparison of conventional spirometric tests and the test of closing volume in an emphysema screening center. Am Rev Respir Dis (1973) 1.30
Prospective study of pulmonary function and lung cancer. Am Rev Respir Dis (1991) 1.29
Angiosarcoma of the liver in Great Britain, 1963-73. Br Med J (1977) 1.26
The effect of smoking cessation and modification on lung function. Am Rev Respir Dis (1976) 1.26
Herculaneum victims of Vesuvius in ad 79. Nature (2001) 1.23
Further investigation into the recent increase in asthma death rates: a review of 41 asthma deaths in Oregon in 1982. Ann Allergy (1988) 1.22
Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA (1993) 1.21
Antithyroid effects of lithium. J Clin Invest (1970) 1.19
Epidemiological studies of PVC manufacturers and fabricators, and primary angiosarcoma of the liver. Proc R Soc Med (1976) 1.15
Myocardial infarction in car assembly workers. Br J Ind Med (1976) 1.15
Acute effects of volcanic ash from Mount Saint Helens on lung function in children. Am Rev Respir Dis (1983) 1.15
Exposures to respirable, airborne Penicillium from a contaminated ventilation system: clinical, environmental and epidemiological aspects. Am Ind Hyg Assoc J (1983) 1.14
Infection risks in hospital staff from blood: hazardous injury rates and acceptance of hepatitis B immunization. J Soc Occup Med (1990) 1.14
The effect of smoking cessation on pulmonary function: a 30-month follow-up of two smoking cessation clinics. Am Rev Respir Dis (1979) 1.13
Health and safety on the farm. BMJ (1992) 1.11
Use of an automated prescription database to identify individuals with asthma. J Clin Epidemiol (1995) 1.11
Polymorphism of monkey thyroxin-binding prealbumin (TBPA): mode of inheritance and hybridization. Endocrinology (1970) 1.09
Preventive health measures in volcanic eruptions. Am J Public Health (1986) 1.08
[The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study]. Dtsch Med Wochenschr (2008) 1.08
Nonoccupational exposures to indoor air pollutants: a survey of state programs and practices. Am J Public Health (1984) 1.07
Effect of sonic treatment on pure cultures and aggregates of bacteria. J Clin Microbiol (1976) 1.07
The relative contribution of body fat and fat pattern to blood pressure level. Hypertension (1985) 1.06
Experience of Black participants in the Lung Health Study smoking cessation intervention program. Nicotine Tob Res (2001) 1.04
Early detection of airways obstruction by the closing volume technique. Chest (1973) 1.02
Occupation and cancer in London: an investigation into nasal and bladder cancer using the Cancer Atlas. Br J Ind Med (1986) 1.01
Ocular effects following the volcanic eruptions of Mount St Helens. Arch Ophthalmol (1983) 1.00
Respiratory symptoms, lung function, and mortality in a screening center cohort. Am J Epidemiol (1989) 0.99
Prediction of the resting metabolic rate in obese patients. Am J Clin Nutr (1983) 0.98
The natural history of air-flow obstruction in PiZ emphysema. Report of an NHLBI workshop. Am Rev Respir Dis (1983) 0.98
Occupational bladder cancer and the hospital clinician. Br J Ind Med (1989) 0.97
Twenty year trends in hospital discharges for asthma among members of a health maintenance organization. J Clin Epidemiol (1992) 0.97
Exposure to antineoplastic drugs in two UK hospital pharmacy units. Ann Occup Hyg (2005) 0.96
Longitudinal versus cross-sectional estimation of lung function decline--further insights. Stat Med (1988) 0.96
Immediate public health concerns and actions in volcanic eruptions: lessons from the Mount St. Helens eruptions, May 18-October 18, 1980. Am J Public Health (1986) 0.96
Smoking cessation in primary care clinics. J Gen Intern Med (1999) 0.96
Relationship of response to a bronchodilator and decline in forced expiratory volume in one second in population studies. Am Rev Respir Dis (1985) 0.94
Volcanic gases and health: Masaya Volcano, Nicaragua. Lancet (1982) 0.93
Methodologic issues in the analysis of lung function data. J Chronic Dis (1987) 0.93
Relationship between lung function and blood pressure in Chinese men and women of Beijing and Guangzhou. PRC-USA Cardiovascular and Cardiopulmonary Epidemiology Research Group. Int J Epidemiol (1998) 0.93
Evaluation of physical health effects due to volcanic hazards: human studies. Am J Public Health (1986) 0.92